CA2449450A1 - Technique et compositions de traitement du cancer - Google Patents
Technique et compositions de traitement du cancer Download PDFInfo
- Publication number
- CA2449450A1 CA2449450A1 CA002449450A CA2449450A CA2449450A1 CA 2449450 A1 CA2449450 A1 CA 2449450A1 CA 002449450 A CA002449450 A CA 002449450A CA 2449450 A CA2449450 A CA 2449450A CA 2449450 A1 CA2449450 A1 CA 2449450A1
- Authority
- CA
- Canada
- Prior art keywords
- treatment
- compound
- cancer
- phorbol
- gingerol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne des compositions pharmaceutiques comprenant: une combinaison d'un composé représenté par la formule (I) dans laquelle R?1¿ est C¿1?-C¿6? alkyle et R?2¿ est indépendamment -H or OH ou un sel de ceux-ci répondant aux normes pharmaceutiques et un composé phorbol. Cette invention concerne aussi d'autres compositions ainsi que les utilisations de toutes ces compositions dans le traitement de cancers ou de tumeurs établis.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29609801P | 2001-06-05 | 2001-06-05 | |
US60/296,098 | 2001-06-05 | ||
PCT/US2002/017705 WO2002098399A2 (fr) | 2001-06-05 | 2002-06-04 | Technique et compositions de traitement du cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2449450A1 true CA2449450A1 (fr) | 2002-12-12 |
Family
ID=23140595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002449450A Abandoned CA2449450A1 (fr) | 2001-06-05 | 2002-06-04 | Technique et compositions de traitement du cancer |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1392266A2 (fr) |
AU (1) | AU2002305823A1 (fr) |
CA (1) | CA2449450A1 (fr) |
WO (1) | WO2002098399A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2411229C2 (ru) * | 2004-09-23 | 2011-02-10 | Учреждение Российской академии наук Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН (ТИБОХ ДВО РАН) | Терапевтические хиноны |
US20080181877A1 (en) * | 2006-03-22 | 2008-07-31 | Leangene Ab, C/O Cit Ekonomiservice Ab | Method For Monitoring the Effect of Compounds on Foxc2 Expression |
FR2950884B1 (fr) * | 2009-10-01 | 2011-11-11 | Oreal | Utilisation de derives de vanilline comme conservateur, procede de conservation, composes et composition |
CN103222986A (zh) * | 2012-01-31 | 2013-07-31 | 岳旺 | 姜辣素与代赭石组合物在制备癌症化疗中减毒增效药物中的用途 |
KR101547735B1 (ko) | 2013-12-09 | 2015-08-26 | 가천대학교 산학협력단 | 파라돌을 포함하는 뇌손상 예방 또는 치료용 조성물 |
KR20240065168A (ko) * | 2015-12-10 | 2024-05-14 | 시므라이즈 아게 | 안정화된 맛 및 냄새를 갖는 조성물 |
US20210244820A1 (en) * | 2018-06-15 | 2021-08-12 | Neonc Technologies, Inc. | Pharmaceutical compositions comprising poh derivatives |
-
2002
- 2002-06-04 WO PCT/US2002/017705 patent/WO2002098399A2/fr not_active Application Discontinuation
- 2002-06-04 CA CA002449450A patent/CA2449450A1/fr not_active Abandoned
- 2002-06-04 EP EP02734677A patent/EP1392266A2/fr not_active Withdrawn
- 2002-06-04 AU AU2002305823A patent/AU2002305823A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002098399A2 (fr) | 2002-12-12 |
WO2002098399A3 (fr) | 2003-02-27 |
EP1392266A2 (fr) | 2004-03-03 |
AU2002305823A1 (en) | 2002-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7410656B2 (en) | Anti-cancer compounds | |
US5945106A (en) | Montoxic extract of Larrea tridentata and method of making the same | |
US20030105031A1 (en) | Methods for the treatment of skin disorders | |
US20120258060A1 (en) | Methods for protecting the skin from radiation insults | |
US9956257B2 (en) | Canola extracts containing high levels of phenolic acids | |
JP5440985B2 (ja) | メラノーマの治療 | |
WO2006009893A2 (fr) | Chimiotherapie anticancereuse | |
US20040156799A1 (en) | Cancer treatment method and compositions | |
US20090239943A1 (en) | Nutraceutical composition and methods for its use | |
JP2004516257A (ja) | 糖尿病性神経障害の治療に対する組成物及びその方法 | |
US20020001573A1 (en) | Immunostimulator anti-cancer compounds | |
CA2449450A1 (fr) | Technique et compositions de traitement du cancer | |
US20080118589A1 (en) | Pharmaceutical formulations of rhodiola crenulata and methods of use thereof | |
WO2014183055A1 (fr) | Méthodes permettant de traiter des affections cutanées au moyen de composés de cyclolignans | |
Sekhar et al. | A review on anticancer potential of natural drugs: hispolon and limonene | |
JP2003171349A (ja) | 新規なジテルペン類、及びこれを用いた組成物、抗炎症剤、抗癌剤 | |
AU748545B2 (en) | Anti-cancer compounds-III | |
WO2011044587A2 (fr) | Composition végétale cytoprotectrice ou thérapeutique | |
AU750628B2 (en) | Anti-cancer compounds-II | |
JP2005528441A (ja) | 運動性能及び/又は持久力を増強するための方法 | |
Pinto et al. | Insight Approaches of Medicinal Plants for the Discovery of Anticancer Drugs | |
LV15503B (lv) | 2h-selenofēn[3,2-h]hromēni izmantošanai vēža profilaksē un ārstēšanā | |
AU4811601A (en) | Anti-cancer compounds-I | |
Grady | The effect of resveratrol on ultraviolet light-induced skin cell death |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 20080604 |